NEW YORK (GenomeWeb) – Cancer Genetics reported today that total first quarter 2015 revenues more than tripled year over year.

The Rutherford, New Jersey-based firm said that for the first three months of 2015 it took in $4.4 million in total revenues, up from $1.4 million in the year ago quarter, due to a revenue contribution from acquisitions and an increase in volume of the firm's SelectOne clinical trials services. Revenues were in line with the consensus Wall Street estimate of $4.4 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A draft bill released by the US House of Representatives appropriations committee would increase the 2019 National Institutes of Health budget by 3 percent.

Bloomberg looks into privacy issues raised by law enforcement's use of genetic genealogy sites.

NBC News reports on the Earth BioGenome Project, which aims to sequence all eukaryotic life on Earth.

In Science this week: environmental DNA can help in studies of marine animals, and more.